The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline
Open accessAbstract
Background: In response to adverse outcomes from prescription opioids, the Centers for Disease Control and Prevention (CDC) released the Guideline for Prescribing Opioids for Chronic Pain in March 2016. Objective: To test the hypothesis that the CDC guideline release corresponded to declines in specific opioid prescribing practices. Design: Interrupted time series analysis of monthly prescribing measures from the IQVIA transactional data warehouse and Real-World Data Longitudinal Prescriptions population-level estimates based on retail pharmacy data. Population size was determined by U.S. Census monthly estimates. Setting: United States, 2012 to 2017. Patients: Persons prescribed opioid analgesics. Measurements: Outcomes included opioid dosage, days supplied, overlapping benzodiazepine prescriptions, and the overall rate of prescribing. Results: The rate of high-dosage prescriptions (≥90 morphine equivalent milligrams per day) was 683 per 100 000 persons in January 2012 and declined by 3.56 (95% CI, -3.79 to -3.32) per month before March 2016 and by 8.00 (CI, -8.69 to -7.31) afterward. Likewise, the percentage of patients with overlapping opioid and benzodiazepine prescriptions was 21.04% in January 2012 and declined by 0.02% (CI, -0.04% to -0.01%) per month before the CDC guideline release and by 0.08% (CI, -0.08% to -0.07%) per month afterward. The overall opioid prescribing rate was 6577 per 100 000 persons in January 2012 and declined by 23.48 (CI, -26.18 to -20.78) each month before the guideline release and by 56.74 (CI, -65.96 to -47.53) per month afterward. Limitation: No control population; inability to determine the appropriateness of opioid prescribing. Conclusion: Several opioid prescribing practices were decreasing before the CDC guideline, but the time of its release was associated with a greater decline. Guidelines may be effective in changing prescribing practices. Primary Funding Source: CDC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Why Don't Physicians Follow Clinical Practice Guidelines?: A Framework for Improvement
Cabana, M. D., Rand, C. S., Powe, N. R., Wu, A. W., Wilson, M. H., Abboud, P.-A. C., & Rubin, H. R. (1999) · JAMA · doi:10.1001/jama.282.15.1458 · Cited by 6,677
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
Segmented regression analysis of interrupted time series studies in medication use research
Wagner, A. K., Soumerai, S. B., Zhang, F., & Ross-Degnan, D. (2002) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2002.00430.x · Cited by 3,279 · cited 2×
“A multiple-group interrupted time series analysis (25, 26) used interaction terms with medication type to test whether the size of the intercept or change in slope at March 2016 was statistically significantly different between medications.”
Interrupted time series regression for the evaluation of public health interventions: a tutorial
Lopez Bernal, J., Cummins, S., & Gasparrini, A. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw098 · Cited by 3,049
Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations
Grimshaw, J. M., & Russell, I. T. (1993) · The Lancet · doi:10.1016/0140-6736(93)92244-n · Cited by 2,770
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain
Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., Donovan, M. I., Fishbain, D. A., Foley, K. M., Fudin, J., et al. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2008.10.008 · Cited by 2,192
Increases in drug and opioid overdose deaths — United States, 2000–2014
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6450a3 · Cited by 1,859
Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths
Bohnert, A. S. B. (2011) · JAMA · doi:10.1001/jama.2011.370 · Cited by 1,509
Self-citationOpioid Prescriptions for Chronic Pain and Overdose: A Cohort Study
Dunn, K. M., Saunders, K. W., Rutter, C. M., Banta-Green, C. J., Merrill, J. O., Sullivan, M. D., Weisner, C. M., Silverberg, M. J., Campbell, C. I., Psaty, B. M., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00006 · Cited by 1,255
Conducting Interrupted Time-series Analysis for Single- and Multiple-group Comparisons
Linden, A. (2015) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1501500208 · Cited by 1,233
Vital signs: changes in opioid prescribing in the United States, 2006-2015.
Guy, G. P., Zhang, K., Bohm, M. K., Losby, J., Lewis, B., Young, R., Murphy, L. B., & Dowell, D. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6626a4 · Cited by 1,117
Self-citationPatterns of abuse among unintentional pharmaceutical overdose fatalities
Hall, A. J. (2008) · JAMA · doi:10.1001/jama.2008.802 · Cited by 815
Opioid Dose and Drug-Related Mortality in Patients With Nonmalignant Pain
Gomes, T., Mamdani, M. M., Dhalla, I. A., Paterson, J. M., & Juurlink, D. N. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.117 · Cited by 638
Park, T. W., Saitz, R., Ganoczy, D., Ilgen, M. A., & Bohnert, A. S. B. (2015) · BMJ · doi:10.1136/bmj.h2698 · Cited by 579
Self-citationCram, P., Fendrick, A. M., Inadomi, J., Cowen, M. E., Carpenter, D., & Vijan, S. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.13.1601 · Cited by 382
Han, B., Compton, W. M., Jones, C. M., & Cai, R. (2015) · JAMA · doi:10.1001/jama.2015.11859 · Cited by 366
Medical Practice Guidelines: Current Activities and Future Directions
Audet, A.-M., Greenfield, S., & Field, M. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-9-709 · Cited by 365
Opioid Prescribing: A Systematic Review and Critical Appraisal of Guidelines for Chronic Pain
Nuckols, T. K., Anderson, L., Popescu, I., Diamant, A. L., Doyle, B., Di Capua, P., & Chou, R. (2014) · Annals of Internal Medicine · doi:10.7326/0003-4819-160-1-201401070-00732 · Cited by 348
Evans, D. G. R., Barwell, J., Eccles, D. M., Collins, A., Izatt, L., Jacobs, C., Donaldson, A., Brady, A. F., Cuthbert, A., Harrison, R., et al. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0442-6 · Cited by 323
Haegerich, T. M., Paulozzi, L. J., Manns, B. J., & Jones, C. M. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.10.001 · Cited by 272
Miller, M., Barber, C. W., Leatherman, S., Fonda, J., Hermos, J. A., Cho, K., & Gagnon, D. R. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.8071 · Cited by 256
(2010) · PsycEXTRA Dataset · doi:10.1037/e562742010-002 · Cited by 224
Addressing the Opioid Epidemic in the United States: Lessons From the Department of Veterans Affairs
Gellad, W. F., Good, C. B., & Shulkin, D. J. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.0147 · Cited by 210
Prescription opioid abuse in patients presenting for methadone maintenance treatment
Brands, B., Blake, J., Sproule, B., Gourlay, D., & Busto, U. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.10.012 · Cited by 190
Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans
Lin, L. A., Bohnert, A. S. B., Kerns, R. D., Clay, M. A., Ganoczy, D., & Ilgen, M. A. (2017) · Pain · doi:10.1097/j.pain.0000000000000837 · Cited by 183
Self-citationPaulozzi, L. J., Weisler, R. H., & Patkar, A. A. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10com06560 · Cited by 153
A Comprehensive set of Postestimation Measures to Enrich Interrupted Time-series Analysis
Linden, A. (2017) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x1701700105 · Cited by 149
Pharmacoepidemiology and Drug Safety
Boshier, A., Shakir, S. A. W., Telfer, P. T., Behr, E., Pakrashi, T., & Camm, A. J. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/(issn)1099-1557 · Cited by 136
Corcoran, P., Griffin, E., Arensman, E., Fitzgerald, A. P., & Perry, I. J. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv058 · Cited by 126
Benzodiazepines and injury: a risk adjusted model
French, D. D., Campbell, R. R., Spehar, A. M., & Angaran, D. M. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.967 · Cited by 36
False Dichotomies and Health Policy Research Designs: Randomized Trials Are Not Always the Answer
Soumerai, S. B., Ceccarelli, R., & Koppel, R. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3841-9 · Cited by 25
Cited by
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7103a1 · Cited by 1,886
Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Tsai, A. C., Kiang, M. V., Barnett, M. L., Beletsky, L., Keyes, K. M., McGinty, E. E., Smith, L. R., Strathdee, S. A., Wakeman, S. E., & Venkataramani, A. S. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002969 · Cited by 437
No Shortcuts to Safer Opioid Prescribing
Dowell, D., Haegerich, T., & Chou, R. (2019) · New England Journal of Medicine · doi:10.1056/nejmp1904190 · Cited by 408
Agnoli, A., Xing, G., Tancredi, D. J., Magnan, E., Jerant, A., & Fenton, J. J. (2021) · JAMA · doi:10.1001/jama.2021.11013 · Cited by 273
Trends and Rapidity of Dose Tapering Among Patients Prescribed Long-term Opioid Therapy, 2008-2017
Fenton, J. J., Agnoli, A. L., Xing, G., Hang, L., Altan, A. E., Tancredi, D. J., Jerant, A., & Magnan, E. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.16271 · Cited by 97
Metadata
- Authors
- Bohnert, A. S. B., Guy, G. P., & Losby, J. L.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2018-09-18
- Volume
- 169
- Issue
- 6
- Pages
- 367-375
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2889024340
- Cited by
- 409
- References
- 32
- FWCI
- 40.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.